Medy-Tox reported third-quarter consolidated operating profit of 15.53 billion won ($11.5 million), up 74.5% from a year earlier, according to a regulatory disclosure Tuesday.

Revenue for the same period fell 2.8% to 59.31 billion won.

Net profit for the period came to 11.62 billion won, a preliminary figure reflecting a 61.4% increase from a year earlier.


jiyoon436@heraldcorp.com